SO-004A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction. (2nd July 2019) - Maglakelidze, M; Yau, T; Bulat, I; Yen, C; Chao, Y; Bai, L; Good, A; Ede, N; Chong, L; Tanasanvimon, S; Charoetum, C; Loong, H; et al.